Загрузка...
A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells
Her2, which is frequently overexpressed in breast cancer, is one of the most studied tumor-associated antigens for cancer therapy. Anti-HER2 monoclonal antibody, trastuzumab, has achieved significant clinical benefits in metastatic breast cancer. In this study, we describe a novel bispecific antibod...
Сохранить в:
| Опубликовано в: : | AMB Express |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844577/ https://ncbi.nlm.nih.gov/pubmed/27112931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13568-016-0201-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|